AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2023
Apr 4, 2023
34187_dirs_2023-04-04_74e454fb-be5b-45cb-9a7e-1c26fda4aa67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-04-01
Reporting Person: BERMAN MICHAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-01 | Common Stock | A | 9491 | — | Acquired | 42827 | Direct |
Footnotes
F1: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended March 31, 2023.
More from InspireMD, Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2
Director's Dealing
2026
Feb 2